Table 2.
Sodiodemographic and clinical characteristics of the sample of 100 OCD patients
| Age, Years, Mean ± SD (Range) | 33.42 ± 9.67 (18–57) | |||
| Male/Female, n (%) | 56/44 (56.0%, 44.0%) | |||
| Age at Onset of OCD, Mean ± SD (Range) | 21.62 ± 10.03 (6–70) | |||
| Baseline Y-BOCS Score, Mean ± SD (Range) | ||||
| Global | 26.26 ± 5.16 (11–36) | |||
| Obsessions | 13.12 ± 3.24 (0-26) | |||
| Compulsions | 12.98 ± 2.99 (0- 19) | |||
| Baseline HDRS, Score, Mean ± SD (Range) | 12.7 ± 5.05 (2–28) | |||
| Current Comorbid Diagnosis, n (%) | ||||
| No comorbid disorder | 53 (53.0) | |||
| Other Anxiety Disorder | 10 (10.0) | |||
| Mood Disorder | 9 (9.0) | |||
| Tics | 3 (3.0) | |||
| Eating Disorders | 2 (2.0) | |||
| Other | 23 (23.0) | |||
| Presence of Dimensions in worst-ever period n (%) | ||||
| Aggresive/checking | 70 (70.0) | |||
| Symmetry/Ordering | 43 (43.0) | |||
| Contamination/cleaning | 49 (49.0) | |||
| Hoarding | 26 (26.0) | |||
| Miscelaneos | 32 (32.0) | |||
| History of Pharmacological Resistance n (%) | ||||
| 1 SSRI | 27 (27.0) | |||
| 2 SSRIs | 12 (12.0) | |||
| >2 SSRIs | 61 (61.0) | |||
| Family Psychiatric History n (% of patients) | 1st grade | 2nd grade | 3rd grade | Total |
| No psychiatric diagnosis | 47 (47.0) | 38 (38.0) | 80 (80.0) | 30 (30.0) |
| OCD | 2 (2.0) | 11 (1.0) | 1 (1.0) | 10 (10.0) |
| Subclinic OCD | 6 (6.0) | 5 (5.0) | 1 (1.0) | 12 (12.0) |
| Anxiety disorder different from OCD | 13 (13.0) | 4 (4.0) | 0 (0.0) | 15 (15.0) |
| Mood disorder | 14 (14.0) | 28 (28.0) | 1 (1.0) | 28 (28.0) |
| Psychotic disorder | 5 (5.0) | 5 (5.0) | 8 (8.0) | 13 (13.0) |
| Drug abuse | 8 (8.0) | 2 (2.0) | 3 (3.0) | 10 (10.0) |
| Eating disorder | 1 (1.0) | 0 (0.0) | 0 (0.0) | 1 (1.0) |
| Tics/ Guilles de la Tourette | 2 (2.0) | 5 (5.0) | 4 (4.0) | 9 (9.0) |
| Others | 2 (2.0) | 2 (2.0) | 2 (2.0) | 5 (5.0) |
OCD obsessive-compulsive disorder, Y-BOCS Yale–Brown obsessive-compulsive scale, HDRS, Hamilton depression rating scale